1 |
曾龙驿. 空腹血糖控制对糖尿病治疗的临床意义[J]. 中国糖尿病杂志, 2012, 20(5): 395-396.
|
2 |
王晓华, 曾雅琳, 郭萃蓉. 非酒精性脂肪性肝病进展性肝纤维化患者空腹血糖受损和胰岛素抵抗调查[J]. 实用肝脏病杂志,2022, 25(6): 812-815.
|
3 |
张雪泠, 钱晓琴. Ⅱ型糖尿病中不同程度非酒精性脂肪肝的比较[J]. 中西医结合心血管病电子杂志,2019, 7(35): 56.
|
4 |
LIM S, TASKINEN M R, BORÉN J. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome [J]. Obesity Rev, 2019, 20(4): 599-611. doi:10.1111/obr.12820
doi: 10.1111/obr.12820
|
5 |
YAN F, NIE G, ZHOU N, et al.. Association of fat-to-muscle ratio with non-alcoholic fatty liver disease: A single-centre retrospective study [J]. BMJ Open, 2023, 13(10): e072489. doi:10.1136/bmjopen-2023-072489
doi: 10.1136/bmjopen-2023-072489
|
6 |
ESLAM M, SANYAL A J, GEORGE J. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease [J]. Gastroenterology, 2020, 158(7): 1999-2014.e1991. doi:10.1053/j.gastro.2019.11.312
doi: 10.1053/j.gastro.2019.11.312
|
7 |
NOGUEIRA J P, CUSI K. Role of Insulin Resistance in the Development of Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: From Bench to Patient Care [J]. Diabetes Spect, 2024, 37(1): 20-28. doi:10.2337/dsi23-0013
doi: 10.2337/dsi23-0013
|
8 |
MARE R, SPOREA I, TOMESCU M, et al. Fibrosis Predictive Score in Caucasian Patients with Metabolic Syndrome [J]. Diabetes Metab Syndr Obes, 2022,15:1703-1713. doi:10.2147/dmso.s358744
doi: 10.2147/dmso.s358744
|
9 |
LI S, FENG L, DING J, et al. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults [J]. BMC gastroenterology, 2023, 23(1): 376. doi:10.1186/s12876-023-03007-8
doi: 10.1186/s12876-023-03007-8
|
10 |
JIN X, XU J, WENG X. Correlation between ratio of fasting blood glucose to high density lipoprotein cholesterol in serum and non-alcoholic fatty liver disease in American adults: A population based analysis [J]. Front Med (Lausanne), 2024,11:1428593. doi:10.3389/fmed.2024.1428593
doi: 10.3389/fmed.2024.1428593
|
11 |
YOUNOSSI Z M, KOENIG A B, ABDELATIF D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes [J]. Hepatology (Baltimore, Md), 2016, 64(1): 73-84. doi:10.1002/hep.28431
doi: 10.1002/hep.28431
|
12 |
SHI Y, MA J, LI S, et al. Sex difference in human diseases: mechanistic insights and clinical implications [J]. Signal Transduct Target Ther, 2024,9(1):238. doi:10.1038/s41392-024-01929-7
doi: 10.1038/s41392-024-01929-7
|
13 |
SUWAŁA S, JUNIK R. Metabolic-associated fatty liver disease and the role of hormones in its aetiopathogenesis [J]. Endokrynol Pol, 2024,75(3):237-252.
|
14 |
PANICKER S, STEPHENS J W. 1565-P: Gender Differences in Clinical Predictors of Nonalcoholic Steatohepatitis in Type 2 Diabetes [J]. Diabetes, 2019, 68(): 10.2337/db19-1565-P. doi:10.2337/db19-1565-p
doi: 10.2337/db19-1565-p
|
15 |
罗娟,刘立伟,刘纪民,等. 非酒精性脂肪性肝病临床和病理特点及进展期纤维化危险因素性别差异的对比研究[J]. 中华肝脏病杂志, 2021, 29(4):6.
|
16 |
徐伟强, 刘淑萍, 李潇萌. 体检人群非酒精性脂肪性肝病检出率及其危险因素分析[J]. 实用肝脏病杂志,2023, 26(1): 35-38.
|
17 |
王燕萍,邬美花,王朝迅,等. 空腹血糖受损合并非酒精性脂肪性肝病患者的危险因素分析[J]. 检验医学与临床,2022,19(14):1922-1925.
|
18 |
ZOU Y, YU M, SHENG G. Association between fasting plasma glucose and nonalcoholic fatty liver disease in a nonobese Chinese population with normal blood lipid levels: A prospective cohort study [J]. Lipid Health Dis, 2020, 19(1): 145. doi:10.1186/s12944-020-01326-3
doi: 10.1186/s12944-020-01326-3
|
19 |
罗珊,冯莹,范丹丹,等. 血管生成素样蛋白8敲除减轻脂多糖诱导的肝脏脂质沉积[J]. 实用医学杂志,2024,40(9):1197-1203.
|
20 |
ZHEN Q, LIANG Q, WANG H, et al. Theabrownin ameliorates liver inflammation, oxidative stress, and fibrosis in MCD diet-fed C57BL/6J mice [J]. Front Endocrinol, 2023, 14:1118925. doi:10.3389/fendo.2023.1118925
doi: 10.3389/fendo.2023.1118925
|
21 |
ZHANG Z, JI G, LI M. Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in NAFLD[J]. Front Endocrinol, 2023, 14:1247611. doi:10.3389/fendo.2023.1247611
doi: 10.3389/fendo.2023.1247611
|
22 |
WU N, ZHAI X, YUAN F, et al. Fasting glucose mediates the influence of genetic variants of SOD2 gene on lean non-alcoholic fatty liver disease [J]. Front Gene, 2022, 13:970854. doi:10.3389/fgene.2022.970854
doi: 10.3389/fgene.2022.970854
|